DMAC vs J · $157.4M cap vs P/E 36, $14.40B cap
DiaMedica Therapeutics Inc (DMAC) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
DMAC does not have a complete income-statement cache yet.
J does not have a complete income-statement cache yet.
DMAC currently screens at market cap $157.4M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the DMAC and J stock pages for the full models.
Not investment advice.